October 7, 2025
LINCOLN, Neb. -- LI-COR announces the launch of the AtmospherIQ™ Gas Analyzers, a new generation of instruments designed for exceptional accuracy, long-term stability, and ease of use. Built to meet the growing need for reliable atmospheric monitoring, AtmospherIQ Gas Analyzers provide world-class performance at lower cost, offering a breakthrough in scalability for expanding city, regional, [...]
Golden Helix Receives a NIH SBIR Phase 2 Grant
October 7, 2025
Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options BOZEMAN, Mont. -- Golden Helix, Inc. announced that it was awarded the NIH SBIR Grant 2R44HG013456-02 "Pharmacogenomics Workflow: Identifying Biomarkers and Treatment Options." Pharmacogenomics is expanding clinicians' ability to deliver personalized medicine, enabling drug selection, dosage, efficacy, and safety to be tailored to each patient's unique biological needs. [...]
October 7, 2025
The first command center for scientific AI, bringing agents and models to every scientist SAN FRANCISCO -- Benchling AI launches today, giving scientists a command center to access AI directly in the platform they trust. At a time where AI is transforming every industry, Benchling is bringing agents and predictive models into the scientific workflow, [...]
Cytiva receives ARPA-H award with ambition to help transform CAR-T cell therapy for solid tumors
October 7, 2025
Anticipated collaboration with leading academic institutions aims to overcome key barriers in cell and gene therapy by targeting solid tumors, enabling in vivo treatment, and radically reducing manufacturing costs Cytiva (Global Life Sciences Solutions USA, LLC), a Danaher company and a global leader in the life sciences industry, will lead a new effort aiming to [...]
PacBio Expands Partnership with seqWell to Bring Scalable Long Read Sample Prep to More Labs
October 7, 2025
Highly scalable, cost-effective LongPlex™ kit delivers streamlined tagmentation and multiplexing for low-pass whole genome sequencing, plasmid resequencing, and microbial sequencing MENLO PARK, Calif. -- PacBio (Nasdaq: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced an expanded partnership with seqWell, a global provider of genomic library and multiplexing workflow solutions. Under the [...]
BrightSpec Names Rick Gordon as CEO
October 6, 2025
New leadership with a proven track record in life sciences will drive commercialization of spectraMRR, the first molecular rotational resonance platform in over 50 years BrightSpec, the leader in molecular rotational resonance (MRR) spectroscopy, today announced the appointment of Rick Gordon as its new Chief Executive Officer. Mr. Gordon joins BrightSpec after successfully growing Halo [...]
October 6, 2025
SALT LAKE CITY -- Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read sequencing, today announced the addition of three Oxford Nanopore–developed research-use-only (RUO) assays to its service portfolio: a Pharmacogenomics (PgX) panel, Telomere Sequencing, and mRNA Vaccine Quality Control. Headquartered in a 20,000sqft CLIA-registered laboratory, [...]
October 6, 2025
Caption: TheraPEAK 293-GT media system for suspension HEK203 cell lines. Caption: TheraPEAK AmpliCell Recombinant Interleukin Cytokines. AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-GT® Medium System aims to help accelerate development timelines and improve consistency from research through to GMP gene therapy production Basel, Switzerland [...]
October 6, 2025
Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours -- Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ Sequencing Workflow – SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a [...]
October 6, 2025
MaxCyte’s Flow Electroporation® Technology will support efficient gene delivery to advance Moonlight Bio’s engineered T cell therapies ROCKVILLE, Md. -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engineering company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics, today announced the signing of a Strategic Platform License (SPL) agreement with [...]

